BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21592629)

  • 21. Sarcoidosis and tocilizumab: is there a link?
    Bustamente L; Buscot M; Marquette CH; Roux C
    Clin Exp Rheumatol; 2017; 35(4):716. PubMed ID: 28516883
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy.
    Thumfart J; Müller D; Rudolph B; Zimmering M; Querfeld U; Haffner D
    Am J Kidney Dis; 2005 Feb; 45(2):411-4. PubMed ID: 15685521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases.
    Ramos-Casals M; Perez-Alvarez R; Perez-de-Lis M; Xaubet A; Bosch X;
    Am J Med; 2011 May; 124(5):386-94. PubMed ID: 21531225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical Mycobacterium marinum infection (Aquarium granuloma) in a patient on TNFα antagonist therapy for psoriatic arthritis.
    Ribot E; Poisnel E; De Biasi C; Roudier J; Balandraud N
    Joint Bone Spine; 2014 May; 81(3):272-3. PubMed ID: 24387972
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab.
    Ahmed MM; Mubashir E; Dossabhoy NR
    Clin Rheumatol; 2007 Aug; 26(8):1346-9. PubMed ID: 16850114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of refractory neurosarcoidosis with Infliximab.
    Santos E; Shaunak S; Renowden S; Scolding NJ
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):241-6. PubMed ID: 18977810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory vertebral sarcoidosis responding to infliximab.
    Garg S; Garg K; Altaf M; Magaldi JA
    J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcoid intermediate uveitis following etanercept treatment: a case report and review of the literature.
    Fonollosa A; Artaraz J; Les I; Martinez-Berriotxoa A; Izquierdo JP; Lopez AS; Gardeazaba J; Berasategui B; Martinez-Alday N
    Ocul Immunol Inflamm; 2012 Feb; 20(1):44-8. PubMed ID: 22017171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary and Lymph Node Sarcoidosis Associated With Anti-Tumor Necrosis Factor Therapy in a Patient With Psoriasis: A New Case of This Paradoxical Phenomenon.
    Padilla-España L; Habicheyn-Hiar S; de Troya M
    Actas Dermosifiliogr; 2015 Nov; 106(9):760-2. PubMed ID: 26076874
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sarcoid-like granulomatosis in patients treated with anti-TNFα].
    Petrovici A; Kaiser MJ; Louis R; Nguyen Dang D
    Rev Med Liege; 2016 Mar; 71(3):124-8. PubMed ID: 27311243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infliximab treatment for chronic sarcoidosis--a case series].
    Jounieaux F; Chapelon C; Valeyre D; Israel Biet D; Cottin V; Tazi A; Fournier E; Wallaert B;
    Rev Mal Respir; 2010 Sep; 27(7):685-92. PubMed ID: 20863968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New-onset paresthesias in inflammatory bowel disease.
    Simonetto DA; Papadakis KA
    Gastroenterology; 2015 May; 148(5):906-7. PubMed ID: 25818847
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
    Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
    Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
    [No Abstract]   [Full Text] [Related]  

  • 34. Sarcoid-related uveitis occurring during adalimumab therapy.
    Seve P; Varron L; Broussolle C; Denis P; Kodjikian L
    Ocul Immunol Inflamm; 2012 Feb; 20(1):59-60. PubMed ID: 22017197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.
    Burns AM; Green PJ; Pasternak S
    J Cutan Pathol; 2012 Feb; 39(2):289-93. PubMed ID: 21899592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist.
    Salama B; Gicquel JJ; Lenoble P; Dighiero PL
    Can J Ophthalmol; 2006 Dec; 41(6):766-8. PubMed ID: 17224962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis.
    Galli F; Lanzolla T; Pietrangeli V; Malviya G; Ricci A; Bruno P; Ragni P; Scopinaro F; Mariotta S; Signore A
    Biomed Res Int; 2015; 2015():401341. PubMed ID: 25866780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.
    Marcella S; Welsh B; Foley P
    Australas J Dermatol; 2011 Aug; 52(3):e8-11. PubMed ID: 21834808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors.
    Cathcart S; Sami N; Elewski B
    J Drugs Dermatol; 2012 May; 11(5):609-12. PubMed ID: 22527429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory failure due to infliximab induced interstitial lung disease.
    Kakavas S; Balis E; Lazarou V; Kouvela M; Tatsis G
    Heart Lung; 2013; 42(6):480-2. PubMed ID: 23969008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.